Polyamine Biomarkers of Parkinson's Disease Progression

被引：0
|
作者：
LeWitt, P. A. [1 ,2 ]
Hong, L. [1 ]
Patil, R. [3 ]
机构：
[1] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA
[2] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA
[3] Univ Cent Florida, Sch Med, Orlando, FL USA
[4] Univ Rochester, Rochester, NY USA
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [41] Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program
    Gwinn, Katrina
    David, Karen K.
    Swanson-Fischer, Christine
    Albin, Roger
    St Hillaire-Clarke, Coryse
    Sieber, Beth-Anne
    Lungu, Codrin
    Bowman, F. DuBois
    Alcalay, Roy N.
    Babcock, Debra
    Dawson, Ted M.
    Dewey, Richard B., Jr.
    Foroud, Tatiana
    German, Dwight
    Huang, Xuemei
    Petyuk, Vlad
    Potashkin, Judith A.
    Saunders-Pullman, Rachel
    Sutherland, Margaret
    Walt, David R.
    West, Andrew B.
    Zhang, Jing
    Chen-Plotkin, Alice
    Scherzer, Clemens R.
    Vaillancourt, David E.
    Rosenthal, Liana S.
    BIOMARKERS IN MEDICINE, 2017, 11 (06) : 451 - 473
  • [42] Disease progression in Parkinson's disease
    Morita, Y.
    Osaki, Y.
    Furushima, T.
    Miyamoto, Y.
    Furuta, K.
    Furuya, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 585 - 585
  • [43] NEOSTRIATAL MORPHOLOGY IN PARKINSON'S DISEASE: IN VIVO BIOMARKERS OF DISEASE PROGRESSION STAGES AND CLINICAL SYMPTOMS
    Owens-Walton, C.
    Jakabek, D.
    Wilkes, F. A.
    Walterfang, M.
    Velakoulis, D.
    van Westen, D.
    Looi, J. C. L.
    Hansson, O.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 48 - 48
  • [44] Biomarkers for Parkinson's disease: Tools to assess Parkinson's disease onset and progression (vol 64, pg S11, 2008)
    不详
    ANNALS OF NEUROLOGY, 2009, 65 (02) : 232 - 232
  • [45] Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
    Shi, Min
    Bradner, Joshua
    Hancock, Aneeka M.
    Chung, Kathryn A.
    Quinn, Joseph F.
    Peskind, Elaine R.
    Galasko, Douglas
    Jankovic, Joseph
    Zabetian, Cyrus P.
    Kim, Hojoong M.
    Leverenz, James B.
    Montine, Thomas J.
    Ginghina, Carmen
    Kang, Un Jung
    Cain, Kevin C.
    Wang, Yu
    Aasly, Jan
    Goldstein, David
    Zhang, Jing
    ANNALS OF NEUROLOGY, 2011, 69 (03) : 570 - 580
  • [46] Metabolomic biomarkers as strong correlates of Parkinson disease progression
    LeWitt, Peter A.
    Li, Jia
    Lu, Mei
    Guo, Lining
    Auinger, Peggy
    NEUROLOGY, 2017, 88 (09) : 862 - 869
  • [47] Biomarkers for Alzheimer's disease and Parkinson's disease
    Growdon, John H.
    Irizarry, Michael C.
    Scherzer, Clemens
    ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 169 - 174
  • [48] Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial Design
    Venuto, Charles S. S.
    Smith, Greta
    Herbst, Konnor
    Zielinski, Robert
    Yung, Norman C. W.
    Grosset, Donald G. G.
    Dorsey, E. Ray
    Kieburtz, Karl
    MOVEMENT DISORDERS, 2023, 38 (10) : 1774 - 1785
  • [49] Paper Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson's disease
    Chan, Lung
    Chung, Chen-Chih
    Yu, Ruan-Ching
    Hong, Chien-Tai
    AGING-US, 2023, 15 (05): : 27 - 27
  • [50] Plasma extracellular vesicle neurofilament light chain as the biomarkers of the progression of Parkinson's disease
    Hong, Chien-Tai
    Chung, Chen-Chih
    Hsieh, Yi-Chen
    Chan, Lung
    BIOMOLECULES AND BIOMEDICINE, 2025, 25 (03): : 588 - 594
12345